Mark Gardner

Mark Gardner has provided regulatory counsel to over 300 medical technology and pharmaceutical makers across the U.S., Canada, Europe, Japan, Australia and Israel. He uses over 20 years of experience to counsel and train clients on compliance, product approvals, ad/promo review, enforcement actions, sunshine reporting, quality and regulatory matters, and privacy. Prior to practicing law, he worked in commercial roles at ev3 (Medtronic), Celleration (Alliqua), and MedTox (LabCorp). He is an Adjunct Professor of Law and HLI advisory board member at Mitchell Hamline School of Law.